(Q36292592)

English

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

type-1 diabetes

0 references

6

object named as

Robin Goland

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Linda A. DiMeglio

4

object named as

Linda A DiMeglio

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

15

object named as

Desmond Schatz

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jeffrey P Krischer

18

object named as

Jeffrey P Krischer

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Carla J Greenbaum

8

object named as

Carla J Greenbaum

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Darrell M. Wilson

17

object named as

Darrell M Wilson

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

19

object named as

Jay S Skyler

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dorothy J Becker

3

object named as

Dorothy J Becker

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Tihamer Orban

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Brian Bundy

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Stephen E Gitelman

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Peter A Gottlieb

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jennifer B Marks

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Roshanak Monzavi

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Antoinette Moran

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Philip Raskin

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Henry Rodriguez

13

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

William E Russell

14

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Diane Wherrett

16

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Type 1 Diabetes TrialNet Abatacept Study Group

20

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

28 June 2011

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

378

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

9789

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

412-419

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Standards of medical care in diabetes--2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Immunotherapy of type 1 diabetes: where are we and where should we be going?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

GAD treatment and insulin secretion in recent-onset type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Type 1 diabetes as a relapsing-remitting disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

A two-signal model for T cell trafficking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

30 September 2017

Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

22 September 2018

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

22 September 2018

Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

22 September 2018

CTLA4Ig: bridging the basic immunology with clinical application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

22 September 2018

Costimulation blockade with belatacept in renal transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

22 September 2018

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

22 September 2018

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

22 September 2018

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3462593

5 December 2018

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960886-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960886-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(11)60886-6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36292592&oldid=2050915494"